HomeEW • NYSE
Edwards Lifesciences Corp
Follow
$61.90
Jul 25, 12:03:03 PM GMT-4 · USD · NYSE · Disclaimer
Key events shows relevant news articles on days with large price movements Key events shows relevant news articles on days with large price movements Key events shows relevant news articles on days with large price movements
Danaher Corp
$273.93
DHR3.02%
Boston Scientific Corporation
$75.87
BSX2.43%
Thermo Fisher Scientific Inc
$596.94
TMO3.86%
Medtronic PLC
$79.97
MDT0.013%
Abbott Laboratories
$106.82
ABT0.40%
Intuitive Surgical, Inc.
$446.35
ISRG1.69%
DexCom Inc
$110.56
DXCM1.23%
Stryker Corp
$335.00
SYK1.61%
Align Technology, Inc.
$230.26
ALGN5.94%
Becton Dickinson and Co
$237.58
BDX0.11%
In the news
Financials
Income Statement
Revenue Net income Fiscal Q1 2024 ended 3/31/24. Reported on 4/25/24. Revenue The total amount of income generated by the sale of goods or services related to the company's primary operations Operating expense Represents the total incurred expenses through normal operations Net income Company’s earnings for a period net of operating costs, taxes, and interest Net profit margin Measures how much net income or profit is generated as a percentage of revenue. Earnings per share Represents the company's profit divided by the outstanding shares of its common stock. EBITDA Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances Effective tax rate The percent of their income that a corporation pays in taxes(USD) Mar 2024info Y/Y change 1.60B 9.50% 774.90M 5.50% 351.90M 3.35% 22.02 -5.62% 0.66 6.45% 476.20M 10.54% 14.26% —
Balance Sheet
Total assets Total liabilities Fiscal Q1 2024 ended 3/31/24. Reported on 4/25/24. Cash and short-term investments Investments that are relatively liquid and have maturities between 3 months and one year Total assets The total amount of assets owned by a company Total liabilities Sum of the combined debts a company owes Total equity The value of subtracting the total liabilities from the total assets of a company Shares outstanding Total number of common shares outstanding as of the latest date disclosed in a financial filing Price to book A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock Return on assets A financial ratio that shows a company’s profitability compared to its assets Return on capital Company’s return above the average cost it pays for its debt and equity capital(USD) Mar 2024info Y/Y change 1.70B 35.35% 9.74B 12.54% 2.55B -1.52% 7.19B — 602.60M — 7.36 — 11.46% — 14.30% —
Cash Flow
Net change in cash Fiscal Q1 2024 ended 3/31/24. Reported on 4/25/24. Net income Company’s earnings for a period net of operating costs, taxes, and interest Cash from operations Net cash used or generated for core business activities Cash from investing Net cash used or generated in investing activities such as purchasing assets Cash from financing Net cash used or generated in financing activities such as dividend payments and loans Net change in cash The amount by which a company's cash balance increases or decreases in an accounting period Free cash flow Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments(USD) Mar 2024info Y/Y change 351.90M 3.35% -53.50M -117.03% 63.10M 12,520.00% 61.70M 129.86% 81.00M -21.97% 105.16M -42.92%
trending_downTop loser A security with one of the largest percentage declines since its last closing price One of the most heavily traded stocks during the last trading session Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned Listed on NYSE Headquartered in Irvine, California, United States
Previous close The last closing price
$86.95
Day range The range between the high and low prices over the past day
$61.73 - $67.80
Year range The range between the high and low prices over the past 52 weeks
$60.57 - $96.12
Market cap A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
37.33B USD
Avg Volume The average number of shares traded each day over the past 30 days
3.21M
P/E ratio The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks
26.64
Dividend yield The ratio of annual dividend to current share price that estimates the dividend return of a stock
-
Primary exchange Listed exchange for this security
NYSE
CDP Climate Change Score A score provided by CDP (formerly the Carbon Disclosure Project) that rates a company on its climate transparency and performance
B
About
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland. Wikipedia Founded 1958 Headquarters Irvine, CaliforniaUnited States Website Employees 19,800